Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.
Zeybel M, Altay O, Arif M, Li X, Yang H, Fredolini C, Akyildiz M, Saglam B, Gonenli MG, Ural D, Kim W, Schwenk JM, Zhang C, Shoaie S, Nielsen J, Uhlén M, Borén J, Mardinoglu A.
Zeybel M, et al. Among authors: fredolini c.
Mol Syst Biol. 2021 Oct;17(10):e10459. doi: 10.15252/msb.202110459.
Mol Syst Biol. 2021.
PMID: 34694070
Free PMC article.
Clinical Trial.